Nearly 400 MEPs and MPs Join Chorus of Voices Calling for a TRIPS Waiver on COVID-19 Vaccines
'Nearly 400 MEPs and MPs Join Chorus of Voices Calling for a TRIPS Waiver on COVID-19 Vaccines', 27 April 2021
The European Commission and European Union (EU) Member States continue to ignore growing calls for a patent waiver that would increase global production and availability of COVID-19 vaccines and related equipment. Recently, nearly 400 Members of the European Parliament (MEPs) and of national Parliaments from across the EU signed a joint appeal expressing their unequivocal support for the measure, adding their voice to that of 175 Nobel laureates and former Heads of State and Governments, the Director General of the World Health Organization (WHO), scientists, trade unions, NGOs and the general public.
In October 2020, South Africa and India submitted a proposal at the World Trade Organization (WTO) to temporarily waive certain intellectual property (IP) rights under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) until widespread vaccination is in place globally. Since then, and despite the growing support for the initiative, the discussions have not gone beyond the exchange of clarifications and additional explanations. This is due to the opposition of a handful of countries, most notably the EU and its Member States, the United States, the United Kingdom and Japan, among others. Supporting the TRIPS waiver would be among the most powerful and effective available ways for governments to demonstrate their commitment to global cooperation and increase global access to vaccines...